Ikarian Capital, LLC Scholar Rock Holding Corp Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.63 - $9.71 $1.54 Million - $1.96 Million	202,100 New	202,100 $1.62 Million
Q1 2024 May 15, 2024	BUY	$13.2 - $17.76 $4.78 Million - $6.43 Million	362,300 New	362,300 $6.43 Million
Q2 2021 Aug 16, 2021	SELL	$26.34 - $46.62 $745,422 - $1.32 Million	-28,300 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$45.96 - $68.02 $1.3 Million - $1.92 Million	28,300 New	28,300 $1.43 Million

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.21B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.